Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

Gamage, Thomas F; Farquhar, Charlotte E; Lefever, Timothy W; Marusich, Julie A; Kevin, Richard C; McGregor, Iain S; Wiley, Jenny L; Thomas, Brian F

Gamage, Thomas F; Farquhar, Charlotte E; Lefever, Timothy W; Marusich, Julie A; Kevin, Richard C; McGregor, Iain S; Wiley, Jenny L; Thomas, Brian F.

Afiliação

Gamage TF; RTI International, Research Triangle Park, North Carolina.
Farquhar CE; RTI International, Research Triangle Park, North Carolina.
Lefever TW; RTI International, Research Triangle Park, North Carolina.
Marusich JA; RTI International, Research Triangle Park, North Carolina.
Kevin RC; The University of Sydney, NSW, 2006, Australia.
McGregor IS; The University of Sydney, NSW, 2006, Australia.
Wiley JL; RTI International, Research Triangle Park, North Carolina.
Thomas BF; RTI International, Research Triangle Park, North Carolina; bft@rti.org.

J Pharmacol Exp Ther ; 365(2): 437-446, 2018 05.

Article em En | MEDLINE | ID: mdl-29549157

Assuntos

1-Naftilamina/análogos & derivados; Canabinoides/farmacologia; Indazóis/farmacologia; 1-Naftilamina/farmacologia; Animais; Células CHO; Cricetulus; AMP Cíclico/metabolismo; Células HEK293; Humanos; Drogas Ilícitas/farmacologia; Masculino; Camundongos; Camundongos Endogâmicos C57BL; Receptor CB1 de Canabinoide/metabolismo; Receptor CB2 de Canabinoide/metabolismo; Transdução de Sinais/efeitos dos fármacos; Valina/análogos & derivados; Valina/farmacologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Indazóis / 1-Naftilamina Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google